BRPI0612628B8 - 1-(2-amina-3-(alquil substituído)-3h-benzimidazolil)metil]-3-substituído-1,3-diidro-benzoimidazol-2-onas com atividade sobre vírus sincicial respiratório, seu processo de preparação e composição farmacêutica que os compreende - Google Patents

1-(2-amina-3-(alquil substituído)-3h-benzimidazolil)metil]-3-substituído-1,3-diidro-benzoimidazol-2-onas com atividade sobre vírus sincicial respiratório, seu processo de preparação e composição farmacêutica que os compreende

Info

Publication number
BRPI0612628B8
BRPI0612628B8 BRPI0612628A BRPI0612628A BRPI0612628B8 BR PI0612628 B8 BRPI0612628 B8 BR PI0612628B8 BR PI0612628 A BRPI0612628 A BR PI0612628A BR PI0612628 A BRPI0612628 A BR PI0612628A BR PI0612628 B8 BRPI0612628 B8 BR PI0612628B8
Authority
BR
Brazil
Prior art keywords
substituted
6alkyl
benzoimidazol
benzimidazolyl
understands
Prior art date
Application number
BRPI0612628A
Other languages
English (en)
Inventor
Marc Maurice Doublet Frédéric
Bonfanti Jean-François
Michel Claude Fortin Jérôme
Muller Philippe
Original Assignee
Janssen R & D Ireland
Janssen Sciences Ireland Uc
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen R & D Ireland, Janssen Sciences Ireland Uc, Tibotec Pharm Ltd filed Critical Janssen R & D Ireland
Publication of BRPI0612628A2 publication Critical patent/BRPI0612628A2/pt
Publication of BRPI0612628B1 publication Critical patent/BRPI0612628B1/pt
Publication of BRPI0612628B8 publication Critical patent/BRPI0612628B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1-(2-amina-3-(alquil substituído)-3h-benzimidazolil)metil]-3-substituído-1,3-diidro-bernzoimidazol-2-onas com atividade sobre vírus sincicial respiratório. a presente invenção refere-se a inibidores de replicação de rsv de fórmula (i) (i) que podem ser representados por fórmula (i) seus sais e formas estereoquimicamente isoméricas, onde r é um radical de fórmula (a) ou (b); (a) (b) q é hidrogênio ou c1-6 alquila opcionalmente substituído por um heterociclo ou q é c1-6 alquila substituído por ambos um radical -or4 e um heterociclo; aik é c1-6 alcanodiila; x é o ou s; -a1=a=2-a3=a4 é -n=ch-ch=ch-, -ch=n-ch=ch-, -ch=ch-n=ch- ou -ch=ch-ch=n-; r1 é ar ou heterociclo; r2 é hidrogênio, c1-6 alquila, c1-6 alquila substituído, c3-7 cicloalquila; r3 é hidrogênio, c1-6 alquila, ciano, aminacarbonila, polihalo c1-6 alquila, c2-6 alquenila ou c2-6 alquinila; r4 é hidrogênio ou c1-6 alquila; ar é fenila ou fenila substituída; het é um heterociclo; composições farmacêuticas contendo compostos (i) e processos para preparação de compostos (i).
BRPI0612628A 2005-06-20 2006-06-20 1-(2-amina-3-(alquil substituído)-3h-benzimidazolil)metil]-3-substituído-1,3-diidro-benzoimidazol-2-onas com atividade sobre vírus sincicial respiratório, seu processo de preparação e composição farmacêutica que os compreende BRPI0612628B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05076438 2005-06-20
EP05076438.0 2005-06-20
PCT/EP2006/063365 WO2006136561A1 (en) 2005-06-20 2006-06-20 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus

Publications (3)

Publication Number Publication Date
BRPI0612628A2 BRPI0612628A2 (pt) 2012-01-03
BRPI0612628B1 BRPI0612628B1 (pt) 2019-12-03
BRPI0612628B8 true BRPI0612628B8 (pt) 2021-05-25

Family

ID=35276402

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612628A BRPI0612628B8 (pt) 2005-06-20 2006-06-20 1-(2-amina-3-(alquil substituído)-3h-benzimidazolil)metil]-3-substituído-1,3-diidro-benzoimidazol-2-onas com atividade sobre vírus sincicial respiratório, seu processo de preparação e composição farmacêutica que os compreende

Country Status (12)

Country Link
US (1) US8034835B2 (pt)
EP (1) EP1896473B1 (pt)
JP (1) JP5078887B2 (pt)
CN (1) CN101203517B (pt)
AT (1) ATE529424T1 (pt)
AU (1) AU2006260969B2 (pt)
BR (1) BRPI0612628B8 (pt)
CA (1) CA2612263C (pt)
MX (1) MX2007016537A (pt)
RU (1) RU2434000C2 (pt)
WO (1) WO2006136561A1 (pt)
ZA (1) ZA200711080B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085357A1 (en) * 2006-01-30 2007-08-02 Euro-Celtique S.A. Cyclourea compounds as calcium channel blockers
TWI650321B (zh) 2011-10-14 2019-02-11 美商安比特生物科學公司 雜環化合物及其使用方法
SG11201600977XA (en) 2013-08-21 2016-03-30 Alios Biopharma Inc Antiviral compounds
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
JO3637B1 (ar) * 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
US10881666B2 (en) 2017-09-29 2021-01-05 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as RSV inhibitors
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
KR20200116099A (ko) 2018-01-31 2020-10-08 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 Rsv에 대한 활성을 갖는 시클로알킬 치환 피라졸로피리미딘
MA52348A (fr) 2018-04-23 2021-03-03 Janssen Sciences Ireland Unlimited Co Composés hétéroaromatiques ayant une activité contre vrs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2376785A1 (en) 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
SK18942001A3 (sk) 1999-06-28 2002-10-08 Janssen Pharmaceutica N. V. Inhibítory replikácie respiračného syncytiálneho vírusu
UA74787C2 (en) 1999-06-28 2006-02-15 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
BRPI0417811A (pt) * 2003-12-18 2007-03-27 Tibotec Pharm Ltd aminobenzimidazóis e benzimidazóis como inibidores da replicação do vìrus sincicial respiratório

Also Published As

Publication number Publication date
AU2006260969A1 (en) 2006-12-28
CN101203517B (zh) 2011-07-06
JP5078887B2 (ja) 2012-11-21
RU2434000C2 (ru) 2011-11-20
ZA200711080B (en) 2009-03-25
MX2007016537A (es) 2008-03-06
RU2008102057A (ru) 2009-07-27
ATE529424T1 (de) 2011-11-15
US8034835B2 (en) 2011-10-11
BRPI0612628B1 (pt) 2019-12-03
CN101203517A (zh) 2008-06-18
WO2006136561A1 (en) 2006-12-28
JP2008546738A (ja) 2008-12-25
CA2612263A1 (en) 2006-12-28
CA2612263C (en) 2015-04-14
EP1896473A1 (en) 2008-03-12
US20100183552A1 (en) 2010-07-22
EP1896473B1 (en) 2011-10-19
AU2006260969B2 (en) 2011-11-17
BRPI0612628A2 (pt) 2012-01-03

Similar Documents

Publication Publication Date Title
BRPI0612628B8 (pt) 1-(2-amina-3-(alquil substituído)-3h-benzimidazolil)metil]-3-substituído-1,3-diidro-benzoimidazol-2-onas com atividade sobre vírus sincicial respiratório, seu processo de preparação e composição farmacêutica que os compreende
NO341617B1 (no) Dihydropyrazolpyrimidinonderivater, deres anvendelse i terapi og til behandling av kreft, deres anvendelse for fremstilling av et medikament, og for anvendelse som strålingssensibilisator, farmasøytisk sammensetning derav, samt et kombinert preparat for administrering ved behandling av kreft.
JP2019516755A5 (pt)
NO20092224L (no) Quiniklidinderivater av (hetero)arylcykloheptankarboksylsyre som muskarinreseptorantagonister
NO20074296L (no) 4-cyklopropyl-1,2,3-tiadiazolforbindelse, agrohortikulturelt plantesykdoms-kontrollmiddel og fremgangsmate for anvendelse av det samme
NO20085169L (no) Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
BRPI0508632A (pt) derivados de n1 ((pirazol-1-ilmetil)-2-metilfenil)-ftalamida e compostos inseticidas relacionados
BRPI0705235A2 (pt) composiÇço agroquÍmica e mÉtodo de fabricaÇço e uso da mesma
UY30897A1 (es) Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones conteniéndolos y aplicaciones
BRPI0606317A2 (pt) compostos de pirazol, uso dos mesmos e composição farmacêutica
ECSP13012373A (es) Derivados y los herbicidas de 6-acil-1,2,4-triazina-3,5-diona
PE20091425A1 (es) Derivados de aminotiazol
IL195877A0 (en) Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
RS54718B1 (en) 1,2,4-THIAZOLIDIN-3-DERIVATIVES AND THEIR USE IN CANCER TREATMENT
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
BRPI0900983B8 (pt) composto de diometina, processo para a síntese do mesmo, composição farmacêutica e seu uso
WO2008015280A3 (de) Wässrige wirkstoffkonzentrate mit herbizider wirkung
WO2009001784A1 (ja) N-フェニル-メタナミン誘導体及びこれを含有する有害生物防除剤
RS51190B (sr) Aminoacilni derivati kao prolekovi i lekovi za lečenje tromboembolijskih bolesti
BRPI0713951B8 (pt) derivados de quinazolina, e composição farmacêutica
NO20074346L (no) Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
WO2009057733A1 (ja) 血管新生阻害活性を有する新規インドール誘導体
AR050860A1 (es) Derivados de 1-deaza-purina 2-sustituidas,con actividad moduladora de receptores de adenosina
BRPI0707203C1 (pt) compostos derivados de indoloquinoxalina úteis para o tratamento de infecções virais, método para preparar os compostos, e, composição farmacêutica
BR112014005990A2 (pt) utilização de fenilpirazolina-3-carboxilatos para melhorar o rendimento de plantas

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: TIBOTEC PHARMACEUTICALS (IE)

B25D Requested change of name of applicant approved

Owner name: JANSSEN R AND D IRELAND (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/12/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/12/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/06/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.